Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000895421-26-000035·CervoMed Inc.
Schedule 13G ownership disclosure
CERVOMED INC
Common Stock · CUSIP: 15713L109
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Morgan Stanley
Shares: 473,681 · Class: 5.1%
- Morgan Stanley Capital Services LLC
Shares: 470,631 · Class: 5.1%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000895421-26-000035
- Form type
- SCHEDULE 13G
- Filer
- CervoMed Inc.
- CIK
- CIK 1053691
- Filed
- Feb 11, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership